Skip to main content

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nurix Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
3 insiders, $1.40M in total
Insiders trading
3
Net value
−$1.40M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nurix Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nurix Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Ring ChristineChief Legal Officer9,110Sep 2, 202618
Hansen GwennChief Scientific Officer117,227Sep 1, 202611
van Houte HansChief Financial Officer40,166Aug 4, 20268
Gregory Julia PDirector10,750May 15, 20261
Reinsdorf Judith ADirector–May 15, 20261
Silva Paul MDirector–May 15, 20261
Baynes Roy D.Director–May 15, 20261
Kapur AnilDirector–May 15, 20261
Lacey David L.Director–May 15, 20261
Dansey Roger DDirector–May 15, 20262
Saltzman Edward CDirector–May 15, 20261
Sands Arthur TPresident, CEO–Feb 10, 20261
Kunkel Lori AnneDirector0May 19, 20250
Wolff StefaniEVP and COO6,113May 2, 20230
Siegall Clay BDirector–May 6, 20220
Beaurang PierreChief Business Officer4,330Aug 11, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 2, 2021 (view filing)Jul 11 dayHansen GwennChief Scientific OfficerSSale−400$26.76−$10.7K−2.8%13.8K after
Jul 12, 2021 (view filing)Jul 12Same dayBeaurang PierreChief Business OfficerSSale−7.50K$23.93−$179.4K−63.4%4.33K after2 lots
Jul 21, 2021 (view filing)Jul 201 dayRing ChristineGeneral CounselSSale−1.20K$27.00−$32.4K−59.9%805 after
Aug 3, 2021 (view filing)Aug 21 dayHansen GwennChief Scientific OfficerSSale−400$31.21−$12.5K−2.8%13.8K after
Aug 11, 2021 (view filing)Aug 101 dayBeaurang PierreChief Business OfficerSSale−7.50K$29.86−$223.9K−63.4%4.33K after2 lots
Aug 11, 2021 (view filing)Aug 101 dayRing ChristineGeneral CounselSSale−1.20K$29.87−$35.8K−59.9%805 after
Sep 2, 2021 (view filing)Sep 11 dayHansen GwennChief Scientific OfficerSSale−400$32.34−$12.9K−2.7%14.2K after
Sep 8, 2021 (view filing)Sep 71 dayHansen GwennChief Scientific OfficerSSale−1.60K$35.00−$56.0K−10.1%14.2K after
Sep 8, 2021 (view filing)Sep 71 dayRing ChristineGeneral CounselSSale−3.20K$35.25−$112.8K−71.3%1.29K after
Sep 13, 2021 (view filing)Sep 103 daysRing ChristineGeneral CounselSSale−2.00K$35.93−$71.9K−60.9%1.29K after3 lots
Oct 4, 2021 (view filing)Oct 13 daysHansen GwennChief Scientific OfficerSSale−400$29.92−$12.0K−2.7%14.2K after
Oct 12, 2021 (view filing)Oct 111 dayRing ChristineGeneral CounselSSale−1.20K$27.36−$32.8K−48.3%1.29K after
Oct 28, 2021 (view filing)Oct 271 dayHansen GwennChief Scientific OfficerSSale−400$35.00−$14.0K−2.7%14.2K after
Oct 28, 2021 (view filing)Oct 271 dayRing ChristineGeneral CounselSSale−800$35.25−$28.2K−38.4%1.29K after
Nov 2, 2021 (view filing)Nov 11 dayHansen GwennChief Scientific OfficerSSale−400$33.24−$13.3K−2.7%14.2K after
Nov 12, 2021 (view filing)Nov 102 daysRing ChristineGeneral CounselSSale−1.20K$32.38−$38.9K−48.3%1.29K after
Dec 2, 2021 (view filing)Dec 11 dayHansen GwennChief Scientific OfficerSSale−400$29.13−$11.7K−2.7%14.2K after
Dec 13, 2021 (view filing)Dec 103 daysRing ChristineGeneral CounselSSale−1.20K$29.04−$34.8K−48.3%1.29K after
Jan 4, 2022 (view filing)Jan 31 dayHansen GwennChief Scientific OfficerSSale−1.83K$28.96−$52.9K−11.4%14.2K after
Jan 11, 2022 (view filing)Jan 101 dayRing ChristineGeneral CounselSSale−1.20K$27.14−$32.6K−48.3%1.29K after
May 3, 2022 (view filing)May 21 dayRing ChristineGeneral CounselSSale−660$11.75−$7.75K−16.2%3.40K after
May 3, 2022 (view filing)May 21 dayvan Houte HansChief Financial OfficerSSale−697$11.75−$8.19K−24.2%2.19K after
May 3, 2022 (view filing)May 21 dayWolff StefaniEVP and COOSSale−330$11.75−$3.88K−34.3%632 after
May 3, 2022 (view filing)May 21 dayHansen GwennChief Scientific OfficerSSale−1.10K$11.75−$12.9K−6.0%17.2K after
Aug 2, 2022 (view filing)Aug 11 dayHansen GwennChief Scientific OfficerSSale−1.19K$15.67−$18.6K−5.8%19.2K after
Aug 2, 2022 (view filing)Aug 11 dayvan Houte HansChief Financial OfficerSSale−752$15.67−$11.8K−1.0%72.7K after
Aug 2, 2022 (view filing)Aug 11 dayWolff StefaniEVP and COOSSale−356$15.67−$5.58K−22.3%1.24K after
Aug 2, 2022 (view filing)Aug 11 dayRing ChristineGeneral CounselSSale−712$15.67−$11.2K−13.4%4.62K after
Nov 1, 2022 (view filing)Oct 311 dayWolff StefaniEVP and COOSSale−350$12.88−$4.51K−9.3%3.40K after
Nov 1, 2022 (view filing)Oct 311 dayHansen GwennChief Scientific OfficerSSale−1.17K$12.88−$15.0K−5.2%21.2K after
Nov 1, 2022 (view filing)Oct 311 dayRing ChristineGeneral CounselSSale−699$12.88−$9.00K−10.2%6.18K after
Nov 1, 2022 (view filing)Oct 311 dayvan Houte HansChief Financial OfficerSSale−739$12.88−$9.52K−1.0%74.8K after
Feb 1, 2023 (view filing)Jan 302 daysHansen GwennChief Scientific OfficerSSale−1.41K$11.78−$16.6K−5.8%23.0K after
Feb 1, 2023 (view filing)Jan 302 daysRing ChristineGeneral CounselSSale−848$11.78−$9.99K−10.5%7.26K after
Feb 1, 2023 (view filing)Jan 302 daysvan Houte HansChief Financial OfficerSSale−924$11.78−$10.9K−1.2%76.8K after
Feb 1, 2023 (view filing)Jan 302 daysWolff StefaniEVP and COOSSale−424$11.78−$4.99K−9.7%3.94K after
May 2, 2023 (view filing)May 11 dayHansen GwennChief Scientific OfficerSSale−1.14K$9.88−$11.2K−4.1%26.6K after
May 2, 2023 (view filing)May 11 dayRing ChristineGeneral CounselSSale−682$9.88−$6.74K−6.4%10.0K after
May 2, 2023 (view filing)May 11 dayvan Houte HansChief Financial OfficerSSale−721$9.88−$7.12K−0.9%78.9K after
May 2, 2023 (view filing)May 11 dayWolff StefaniEVP and COOSSale−342$9.88−$3.38K−5.3%6.11K after
Aug 1, 2023 (view filing)Jul 311 dayHansen GwennChief Scientific OfficerSSale−1.88K$9.65−$18.2K−5.9%30.0K after
Aug 1, 2023 (view filing)Jul 311 dayRing ChristineGeneral CounselSSale−1.42K$9.65−$13.7K−10.2%12.5K after
Aug 1, 2023 (view filing)Jul 311 dayvan Houte HansChief Financial OfficerSSale−1.25K$9.65−$12.0K−1.5%82.6K after
Nov 1, 2023 (view filing)Oct 311 dayHansen GwennChief Scientific OfficerSSale−1.63K$5.20−$8.49K−4.6%33.5K after
Nov 1, 2023 (view filing)Oct 311 dayRing ChristineChief Legal OfficerSSale−1.23K$5.20−$6.41K−7.5%15.3K after
Nov 1, 2023 (view filing)Oct 311 dayvan Houte HansChief Financial OfficerSSale−1.08K$5.20−$5.62K−1.2%86.4K after
Dec 20, 2023 (view filing)Dec 191 dayvan Houte HansChief Financial OfficerSSale−10.9K$10.00−$109.1K−12.6%75.5K after10b5-1
Dec 21, 2023 (view filing)Dec 201 dayvan Houte HansChief Financial OfficerSSale−3.54K$10.00−$35.4K−4.7%71.9K after10b5-1
Jan 30, 2024 (view filing)Jan 30Same dayRing ChristineChief Legal OfficerSSale−1.76K$7.99−$14.1K−9.2%17.4K after
Jan 30, 2024 (view filing)Jan 30Same dayHansen GwennChief Scientific OfficerSSale−2.33K$7.99−$18.6K−6.0%36.4K after